Orthofix Medical (OFIX) EPS (Weighted Average and Diluted) (2016 - 2025)
Orthofix Medical (OFIX) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with -$0.05 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) rose 93.33% year-over-year to -$0.05, compared with a TTM value of -$2.33 through Dec 2025, up 29.18%, and an annual FY2025 reading of -$2.33, up 29.39% over the prior year.
- EPS (Weighted Average and Diluted) was -$0.05 for Q4 2025 at Orthofix Medical, up from -$0.57 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.12 in Q2 2021 and bottomed at -$1.71 in Q1 2023.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.62, with a median of -$0.58 recorded in 2023.
- The sharpest move saw EPS (Weighted Average and Diluted) skyrocketed 112.5% in 2021, then tumbled 991.67% in 2023.
- Year by year, EPS (Weighted Average and Diluted) stood at -$1.67 in 2021, then skyrocketed by 79.04% to -$0.35 in 2022, then plummeted by 68.57% to -$0.59 in 2023, then decreased by 27.12% to -$0.75 in 2024, then surged by 93.33% to -$0.05 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for OFIX at -$0.05 in Q4 2025, -$0.57 in Q3 2025, and -$0.36 in Q2 2025.